Clinical Research Directory

Inclusion Criteria: * Patients with two or more similar patches of stable vitiligo "absence of new patches of depigmentation or enlargement of the pre-existing patches" for 6 months at least. * Patients who will accept to be enrolled in the study and will sign an informed consent. Exclusion Criteria: * Unstable vitiligo for more than 6 months. * Current bacterial or viral infection in the treatment area. * Patients with unrealistic expectation. * Very thin patients "poor donor areas". * Patients with uncontrolled systemic disease such as diabetes or hypertension. * Patients with hepatitis B or C virus infection. * Patients with any other skin disease. * Patients with bleeding or coagulopathy disorders. * Pregnancy and lactation. * Patients who received topical treatment for vitiligo during the last month, or systemic treatment during the past three months before the study.